Alta Partners — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Berkeley, US
Peter Calthorpe(Executive Officer, Director)
Board seatGarrett Gruener· per SEC Form D · $2M raise · filed Jul 2019
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions.
BiotechHealthtechMedical DevicesPittsburgh, US
Suma M. Krishnan(Director)Krish S. Krishnan(Chairman & CEO)Suma Krishnan(President, Research & Development)inKrish Krishnan(Chairman & CEO)inDoug Norby(Director)Dino Rossi(Director)
Board seatDan Janney· per SEC Form D · $11.3M raise · filed Aug 2017
Co-investorsAvoro Capital AdvisorsFrazier Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.